Medical Design & Development’s Post

Once again, MicroPort tops Medical Design & Outsourcing’s Big 100 when it comes to the percentage of revenue spent on research & development (R&D). MicroPort spends 49.9% of its revenue on R&D. MicroPort ranks seventy-seventh overall on the Big 100

If you were walking around the showroom floor this past weekend at the #aao2023 meeting in San Francisco, you probably heard the words “connectivity, “cloud-based,” and “efficiency” a lot. With the demand for ophthalmic procedures continuing to increase in parallel with an aging population, physicians are increasingly looking for ways to save time, without compromising a high level of care. Industry partners have taken notice and are now offering digital enhancements to the cataract, corneal refractive, and retina workflows like never before. Digital connectivity between devices and cloud-based software solutions are eliminating many manual steps to surgery and the preoperative process, while also providing more personalized care. Here is a summary of some of the new products released at AAO that aim to increase efficiency. ZEISS Medical Technology Alcon Bausch + Lomb Topcon Healthcare https://lnkd.in/gmtph2ep

Catheter Precision (NYSE American: VTAK): Unveiling the Extraordinary Potential of an Emerging Medical Technology Powerhouse: Catheter Precision Inc. (NYSE American: VTAK) is involved in the development and delivery of electrophysiology-related products that are meant for patients, physicians, and hospitals. These products equip the target customers with unique solutions and technologies for the purpose of improving … Continue reading → #Business #FinancialMarket

We are pleased to share that Northland Capital Markets has initiated independent equity research coverage of Envoy Medical (NASDAQ: COCH). This marks the second institutional research firm to launch coverage since Envoy Medical's Nasdaq listing earlier this year; Lake Street Capital Markets initiated coverage at the end of November. These reports are independent of Envoy Medical and reflect the analysts’ views on Envoy Medical's opportunity to disrupt the multi-billion-dollar cochlear implant market with a fully implanted cochlear device. The device, known as the Acclaim®, is expected to be the first of its kind in the cochlear implant industry, as it will be fully implanted and use the ear, not a microphone, to pick up sound.   Interested investors can learn more about Envoy Medical's technology, view an overview investor presentation, or listen to a replay of the December fireside chat with the covering research analyst at Lake Street Capital Markets and key medical professionals experienced with the Acclaim device on the company website: www.envoymedical.com.    #nasdaq #coch #research #envoymedical

#Technology is allowing the #medical field to make incredible advancements in #research, #diagnostics and treatment, including #drug discovery and development. Read more about #DigitalTwins 👇 https://lnkd.in/eWUbvjCW #healthtech #medtech #medicaltech #medicalinnovation #tech #medicaladvancement #medicalfield #medicalresearch #drugdevelopment #drugdiscovery #innovation #healthcare #pharma #pharmaceuticals #science #lifesciences #researchanddevelopment #biotech #health #healthsector #investing #investment #healthcareinvestment #privateequity #pe #trenchantcapital #trenchant #TCC #tcc

4K Medical Imaging Market, Size & Forecast 2024-2030, Featuring Profiles of Stryker, Zimmer Biomet Holdings, Smith & Nephew, Conmed, Medtronic, Sony, Fujifim and Hitachi: DUBLIN, Dec. 6, 2023 /PRNewswire/ -- The "4K Medical Imaging Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering. The 4K Medical Imaging Market size will attain US$...

Edward Lifesciences Acquires ARC Spinout Innovalve Bio Medical - HIT Consultant #Acquisition: Edward Lifesciences Acquires Innovalve Bio Medical In a recent move, Edward Lifesciences has acquired Innovalve Bio Medical, a spinout from ARC. This acquisition marks a significant development in the healthcare industry, particularly in the field of medical devices and technology. #Strategic Expansion: Strengthening Edward Lifesciences' Portfolio The acquisition of Innovalve Bio Medical is part of Edward Lifesciences' strategic expansion plan to strengthen its portfolio in the medical device market. By incorporating Innovalve's innovative technologies and products, Edward Lifesciences aims to enhance its offerings and provide better solutions for patients. #Innovation: Leveraging Innovalve's Technology In ai.mediformatica.com #innovation #medical #acquisition #this #technology #israel #healthcare #heart #shebamedicalcenter #healthcareinnovation #patients #surgical #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3y0Ieqp)

𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗦𝘂𝗿𝗴𝗶𝗰𝗮𝗹 𝗘𝗻𝗲𝗿𝗴𝘆: 𝗧𝗿𝗲𝗻𝗱𝘀 𝗶𝗻 𝗘𝗹𝗲𝗰𝘁𝗿𝗼𝘀𝘂𝗿𝗴𝗶𝗰𝗮𝗹 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗼𝗿 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 The manufacturing, distributing, and using of medical equipment for the purpose of supplying electrical energy for different surgical operations, such as tissue ablation, coagulation, and cutting, constitute the #Surgical #Generators. Known by another name, electrosurgical units (ESUs), these generators use high-frequency electrical currents to minimize tissue damage and blood loss during precision surgical activities. 𝗦𝘂𝗿𝗴𝗶𝗰𝗮𝗹 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗼𝗿𝘀 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝘀𝗶𝘇𝗲 𝘄𝗮𝘀 𝘃𝗮𝗹𝘂𝗲𝗱 𝗮𝘁 𝗨𝗦𝗗 𝟰𝟲𝟰.𝟯𝟬 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝟮𝟬𝟮𝟮, 𝗮𝗻𝗱 𝗶𝘀 𝗽𝗿𝗼𝗷𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗿𝗲𝗮𝗰𝗵 𝗨𝗦𝗗 𝟲𝟯𝟱.𝟰𝟯 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟯𝟬, 𝗴𝗿𝗼𝘄𝗶𝗻𝗴 𝗮𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟰% 𝗳𝗿𝗼𝗺 𝟮𝟬𝟮𝟮 𝘁𝗼 𝟮𝟬𝟯𝟬. ⏩𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 >> https://lnkd.in/d_Sz_mwd 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: BOSTON SCIENTIFIC CORPORATION (U.S) OLYMPUS CORPORATION (JAPAN) CONMED CORPORATION (U.S) ERBE USA INCORPORATED (GERMANY) BOVIE MEDICAL (U.S) MEDTRONIC PLC (IRELAND) B. BRAUN MELSUNGEN AG (GERMANY) KLS MARTIN GROUP (GERMANY) 𝗞𝗲𝘆 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀 𝗜𝗻 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟭, Boston Scientific Corporation announced the acquisition of Baylis Medical Company Inc., giving Boston Scientific the potential to extend its electrophysiology and structural heart portfolios. 𝗜𝗻 𝗝𝘂𝗻𝗲 𝟮𝟬𝟮𝟭, Ethicon, a Johnson & Johnson Medical Devices Company, introduced the ENSEAL X1 Curved Jaw Tissue Sealer, a new sophisticated bipolar energy device. It is a novel sophisticated bipolar energy device that improves procedure efficiency and seal strength. #surgicalgenerators #electrosurgery #medicaldevices #surgicaltechnology #surgicalsafety #surgicalprecision #medicalelectronics #surgerytools

Andrea Park for Fierce Medtech with the story on Synchron's equity investment in manufacturing partner Acquandas GmbH: "Synchron recently completed patient enrollment of its U.S.-based COMMAND trial, which recruited six patients with severe paralysis to assess the safety of the device and whether it could help translate thoughts into digital actions such as texting, emailing and shopping online. An earlier study in Australia showed that the device remained safely in place after one year in all four of its participants, one of whom was also able to use the technology to send what Synchron described as the first tweet crafted using direct thought. Next up, the Fierce 15 honoree is planning to launch a U.S. pivotal trial of the technology, the results of which would be used to apply for FDA approval of the device. In other recent moves to prepare for that hopeful regulatory green light, Synchron announced at the start of this year that it had appointed Riki Banerjee as its new CTO. Previously a longtime veteran of Medtronic’s neuromodulation division and, since 2021, Synchron’s VP of R&D, she took over the tech chief role from Professor Nicholas Opie, Ph.D., who’d held the title since he co-founded Synchron and who remains on the board. Read the full article: https://lnkd.in/eKHUNDFF #BCI #neurotech #braincomputerinterface

Key Takeaways from Europe's Medtech Sector According to a recent blog post on Silicon Republic, here are the most significant takeaways regarding Europe's medtech industry: 1. Significant Growth: The European medtech market was estimated to be roughly €160bn in 2022, with AI-based patent applications filed by the sector almost quadrupling since 2018. 2. Innovations in Ireland and Europe: Numerous successful medtech innovations, investments, and startups are advancing within the region, with Ireland being a significant contributor. 3. Regulatory Challenges: Despite the strengths, EU Medical Device Regulations (MDR) and In-vitro Diagnostic Medical Devices Regulation (IVDR) could potentially act as barriers to future innovations, with industry players calling for regulatory changes. Check out the full article for more insights: https://lnkd.in/eKY-s2Qb Let's discuss - Do you think regulatory frameworks can sometimes stifle innovation in sectors like medtech? #MedTech #Europe #Innovation #Regulation